Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 25, 2020

Primary Completion Date

August 3, 2022

Study Completion Date

August 3, 2022

Conditions
Ulcerative Colitis
Interventions
DRUG

Etrasimod

Etrasimod 2 mg tablet by mouth, once daily up to 52 weeks

DRUG

Placebo

Etrasimod matching placebo tablet by mouth, once daily up to 52 weeks

Trial Locations (38)

457-8511

Kojunkai Daido Clinic, Nagoya

Kojunkai Daido Hospital, Nagoya

467-8602

Nagoya City University Hospital, Nagoya

441-8570

Toyohashi Municipal Hospital, Toyohashi

277-0871

Tsujinaka Hospital Kashiwanoha, Kashiwa-shi

270-0116

Ishii Eye Clinic, Nagareyama-shi

814-0180

Fukuoka University Hospital, Fukuoka

816-0863

Takimoto Eye Clinic(OCT), Kasuga-shi

816-0864

Fakuoka Tokushukai Hospital, Kasuga-shi

501-1194

Gifu University Hospital, Gifu

373-8585

SUBARU Health Insurance Society Ota Memorial Hospital, Ota-shi

734-8551

Hiroshima University Hospital, Hiroshima

070-8610

Asahikawa City Hospital, Asahikawa-shi

311-3193

NHO Mito Medical Center, Higashiibaraki-gun

302-0014

Matsumoto Eye Clinic, Toride-shi

920-8650

NHO Kanazawa Medical Center, Kanazawa

760-0017

Takamatsu Red Cross Hospital, Takamatsu

760-8557

Kagawa Prefectural Central Hospital, Takamatsu

890-0062

JA- Kagoshima Koseiren Hospital (PET/DLCO), Kagoshima

Kagoshima Kouseiren Hospital, Kagoshima

892-0813

Clinical Pathology Laboratory (Diagnostick center), Kagoshima

892-0824

Jiaikai Idzuro Imamura Hospital, Kagoshima

892-0825

Sameshima Eye Clinic (OCT), Kagoshima

892-0846

Sameshima Hospital, Kagoshima

861-8520

Japanese Red Cross Kumamoto Hospital, Kumamoto

612-8555

National Hospital Organization Kyoto Medical Center, Kyoto

514-8507

Mie University Hospital, Tsu

510-8561

Mie Prefectural General Medical Center, Yokkaichi-shi

981-8563

JOHAS Tohoku Rokai Hospital, Sendai

JOHAS Tohoku Rosai Hospital, Sendai

982-8502

Sendai City Hospital, Sendai

553-0003

Japan Community Health care Organization Osaka Hospital, Osaka

849-8501

Saga University Hospital, Saga

104-8560

St. Luke's International Hospital, Chuo-ku

187-8510

Showa General Hospital, Kodaira-shi

108-8642

Kitasato University Kitasato Institute Hospital, Minato-ku

169-0073

JCHO Tokyo Yamate Medical Center, Shinjuku-ku

641-8510

Wakayama Medical University Hospital, Wakayama

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Arena is a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Pfizer

INDUSTRY